|
Fernández Villa N., Manzano Fernández S., Gómez Molina M., Garrido Bravo I.P., Pascual Figal D.A., Pastor Pérez F.J. Intravenous acetazolamide in patients with acute heart failure and persistent volume overload. Revista Espanola de Cardiologia. 2025. 10.1016/j.recesp.2025.01.002
AÑO: 2025; IF: 7.2
|
|
Martínez-Pérez J.E., Sánchez-Martínez F.I., Abellán-Perpiñán J.M., Pascual-Figal D. The Monetary Value of a Statistical Life in the Context of Atherosclerotic Cardiovascular Disease. PharmacoEconomics. 2025. 10.1007/s40273-025-01482-3
AÑO: 2025; IF: 4.6
|
|
Arribas-Leal JM, Jimenez-Aceituna A, Aranda-Domene R, Fernandez-Villa N, Lorenzo-Diaz M, Rivera-Caravaca JM, Domingo-Zambudio J, Perez-Andreu J, Pastor-Perez FJ, Garcia-Puente Del Corral J, Fernandez-Perez JM, Gutierrez-Garcia F, Royo-Villanova M, Pascual-Figal DA, Jara-Rubio R, Canovas-Lopez S, Garrido-Bravo IP. Spanish Center's Early Experience With Donation Following Circulatory Death in Heart Transplantation. ASAIO J. 2025 May 14. doi: 10.1097/MAT.0000000000002458. Online ahead of print. PubMed PMID: 40377428.
AÑO: 2025; IF: 2.3
|
|
Asensio Lopez MDC, Ruiz Ballester M, Bastida Nicolas FJ, Soler Pardo F, Alonso-Romero JL, Caro-Martinez C, Pascual Figal D, Lax A. miR-106b-5p as a Central Regulator of Cancer Progression and Chemotherapy-Induced Cardiotoxicity: From Molecular Mechanisms to Clinical Translation. Int J Mol Sci. 2025 Oct 14;26(20):10002. doi: 10.3390/ijms262010002. PubMed PMID: 41155295; PubMed Central PMCID: PMC12562630.
AÑO: 2025; IF: 4.9
|
|
Roldan-Medina M, Riquelme-Perez A, Lopez-Palop R, Carrillo P, Lacunza J, Valdesuso R, de Lara JG, Hurtado-Martinez J, Duran JM, Pinar-Bermudez E, Gimeno JR, Pascual-Figal D. Heparin pretreatment for STEMI primary angioplasty: a meta-analysis. REC Interv Cardiol. 2025 Jul 2;7(4):229-237. doi: 10.24875/RECICE.M25000517. eCollection 2025. PubMed PMID: 41333129; PubMed Central PMCID: PMC12666643.
AÑO: 2025; IF: 1.1
|